False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test
- 1 January 1997
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 35 (1) , 174-178
- https://doi.org/10.1128/jcm.35.1.174-178.1997
Abstract
Although tests for detection of immunoglobulin M (IgM) toxoplasma antibodies have been reported to have a high degree of accuracy, it is well recognized by investigators in the United States and Europe that false-positive results may occur with many of these tests, at times to an alarming degree. Unfortunately, this information is not well documented in the literature. Studies on various toxoplasma IgM test kits are frequently flawed. The investigators often use reference tests which have not previously been carefully evaluated as well as sera that were not appropriate to answer the question of how often false-positive results might occur. We recently had the unique opportunity to evaluate the accuracy of the Platelia Toxo IgM test in 575 serum samples obtained during an outbreak of toxoplasmosis which occurred in 1995 in the Capital Regional District of British Columbia, Canada. When compared with results obtained in a reference IgM enzyme-linked immunosorbent assay (ELISA), the Platelia Toxo IgM test had a sensitivity of 99.4%, specificity of 49.2%, positive predictive value of 51.9%, negative predictive value of 99.3%, and an overall agreement of 67.0%. In an attempt to resolve discrepancies between these two tests, a serological profile (Sabin-Feldman dye test, IgA and IgE antibody tests, differential agglutination [AC/HS] test, and IgG avidity method) was performed. Of 153 serum samples that were positive in the Platelia Toxo IgM test and negative in the IgM ELISA, 71 (46.4%) were negative in the Sabin-Feldman dye test. Of the serum samples that were positive in the dye test, 77 (93.9%) had a serological profile most compatible with an infection acquired in the distant past. These results reveal high numbers of false-positive results in the Platelia Toxo IgM test and highlight the importance of appropriate evaluation of commercial tests that are currently being marked. Our results also emphasize the importance of confirmatory testing to determine whether the results of an IgM antibody test reflect the likelihood of a recently acquired infection.Keywords
This publication has 25 references indexed in Scilit:
- Multicenter evaluation of a new commercial assay for detection of immunoglobulin M antibodies toToxoplasma gondiiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Studies on the Serodiagnosis of Toxoplasmic LymphadenitisClinical Infectious Diseases, 1995
- Measurement of toxoplasma IgM by a microparticle capture enzyme immuno-assayJournal of Medical Microbiology, 1993
- Comparison of relative uses of commercial assays for Toxoplasma gondii IgM antibodies.Journal of Clinical Pathology, 1992
- Automated microparticle enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii.Journal of Clinical Pathology, 1991
- High Levels of IgM Antibodies Specific forToxoplasma gondiiin Pregnancy 12 Years after Primary Toxoplasma InfectionGynecologic and Obstetric Investigation, 1991
- Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii.Journal of Clinical Pathology, 1989
- Five commercial enzyme linked immunosorbent assay kits for toxoplasma specific IgM antibody.Journal of Clinical Pathology, 1989
- Comparative study of three immunoassays for detection of immunoglobulin M antibodies againstToxoplasma gondiiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- An Enzyme-Linked Immunosorbent Assay for Detection of IgM Antibodies to Toxoplasma gondii: Use for Diagnosis of Acute Acquired ToxoplasmosisThe Journal of Infectious Diseases, 1980